| Results summary | View all lists in L2L MDB | View all genes in C01C.profile.u50 |
|
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 3.09-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 218729_AT | LXN | latexin | |||||||||||
| 204698_AT | ISG20 | G | R | interferon stimulated exonuclease gene 20kDa | |||||||||
| 201631_S_AT | IER3 | G | immediate early response 3 | ||||||||||
| 201925_S_AT | CD55 | X | P | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | |||||||||
| 203821_AT | HBEGF | G | D | X | S | heparin-binding EGF-like growth factor | |||||||